Mealey's (April 17, 2017, 1:23 PM EDT) -- PHILADELPHIA — A Pennsylvania federal judge on April 11 denied a motion by Pfizer Inc. to dismiss a False Claims Act, 31 U.S.C. § 3729, et seq., lawsuit alleging that the company engaged in off-label promotion of the anti-fungal drug Vfend and paid kickbacks to doctors in exchange for prescribing the drug (United States of America, ex rel. Catherine A. Brown, et al. v. Pfizer, Inc., No. 05-6795, E.D. Pa., 2017 U.S. Dist. LEXIS 55656)....